↓ Skip to main content

Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients

Overview of attention for article published in BMC Infectious Diseases, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
101 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients
Published in
BMC Infectious Diseases, May 2013
DOI 10.1186/1471-2334-13-216
Pubmed ID
Authors

So Ri Kim, Lae Young Jung, In-Jae Oh, Young-Chul Kim, Kyeong-Cheol Shin, Min Ki Lee, Sei-Hoon Yang, Hee Sun Park, Mi-Kyung Kim, Jin Young Kwak, Soo-Jung Um, Seung Won Ra, Woo Jin Kim, Seungsoo Kim, Eu-Gene Choi, Yong Chul Lee

Abstract

BACKGROUND: Pulmonary actinomycosis is a chronic pulmonary infection caused by Actinomyces. Both improving oral hygiene and early application of antibiotics to the case of suspicious pulmonary infections result in changes in incidences and presentations of pulmonary actinomycosis. However, there are little reports dealt with the recent clinical characteristics of pulmonary actinomycosis. This study aimed to review the characteristics of pulmonary actinomycosis occurred during the first decade of 21st century. METHODS: This retrospective study was performed on 94 subjects with pulmonary actinomycosis diagnosed pathologically from January 2000 to December 2010 in 13 hospitals in Korea. RESULTS: The data of the study showed that pulmonary actinomycosis occurs frequently in middle to old-aged males (mean age; 57.7 years old) and that the most common symptoms are cough, hemoptysis, and sputum production. Various radiologic features such as the consolidation with central low attenuation (74. 5%) and no regional predominance were also observed. Most of patients recovered completely with medical and/or surgical treatment, reaching approximately 98% cure rate. CONCLUSIONS: The results demonstrate that pulmonary actinomycosis is one of the cautious pulmonary diseases. More importantly, in cases of persistent hemoptysis or for differential diagnosis from lung malignancy, our data have revealed that surgical resection appears to be a useful intervention and that radiologic diagnosis may not provide decisive information. These findings indicate that it is important for the clinicians to include pulmonary actinomycosis as one of differential diagnoses for refractory pulmonary abnormal lesions to the current usual management.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 1%
Unknown 66 99%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 9 13%
Student > Ph. D. Student 7 10%
Researcher 7 10%
Student > Bachelor 6 9%
Student > Master 6 9%
Other 17 25%
Unknown 15 22%
Readers by discipline Count As %
Medicine and Dentistry 34 51%
Agricultural and Biological Sciences 5 7%
Immunology and Microbiology 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Other 4 6%
Unknown 18 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2020.
All research outputs
#14,170,039
of 22,710,079 outputs
Outputs from BMC Infectious Diseases
#3,749
of 7,653 outputs
Outputs of similar age
#109,278
of 194,054 outputs
Outputs of similar age from BMC Infectious Diseases
#77
of 137 outputs
Altmetric has tracked 22,710,079 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,653 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,054 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 137 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.